← FDA DRUG APPROVALS

FDA ANDA · ANDA086720

THEOPHYLLINE

Sponsor: PHARM ASSOC

APPLICATION
ANDA086720
TYPE
ANDA
ORIGINAL APPROVAL
1980-06-25
LATEST ACTION
1996-03-01
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Discontinued

Products

THEOPHYLLINEDiscontinued
THEOPHYLLINE 80MG/15ML · ELIXIR · ORAL

Approval history

1996-03-01Labeling · Supplement 11AP
1990-03-26Labeling · Supplement 10AP
1988-07-15Labeling · Supplement 7AP
1983-07-18Manufacturing (CMC) · Supplement 3AP
1980-06-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →